Healthcare AI News 6/26/24

News

The Coalition for Health AI publishes a draft framework for the responsible use of AI in healthcare and solicits public comment. CHAI also posted a draft document of Assurance Reporting Checklists for self-reporting and self-review for assuring that AI solutions meet criteria in five areas: (1) usefulness, usability, and efficacy; (2) fairness, equity, and bias management; (3) safety; (4) transparency and intelligibility; and (5) privacy and security.

In Japan, SoftBank Group founder Masayoshi Son will make a rare public appearance in a Thursday panel discussion on bringing AI to healthcare in his country. The investment group took a significant position in Tempus AI just before its recent IPO and has signed an agreement to set up similar services in Japan.

Business

Wolters Kluwer Health will add AI-powered adaptive learning to its nursing education products.

Oracle announces GA of Clinical Digital Assistant ambient documentation and voice command system for ambulatory clinics that use its EHR.

Solventum, formerly 3M Health Care, announces an AI-driven payment denials prediction solution.

Real-world data vendor Atropos Health expands its Evidence Network to 300 million patients with the addition of two new partners. The company’s products can generate publication-grade, AI-powered observational studies from clinical questions with a two-day turnaround.

Shares in AI-enabled precision medicine vendor Tempus AI have lost one-third of their value since the company’s June 14 IPO. The company’s $8 billion pre-IPO valuation in 2022 is at $4.5 billion. Shares rose Wednesday on news that FDA has cleared sale of its atrial fibrillation detection algorithm for 12-lead ECGs.

Research

NIH awards Cleveland Clinic and other organizations a $2.8 million grant to study the use of AI to analyze MRIs to determine how rectal tumors are responding to therapy. Researchers hope to develop radiomic signatures using radiology and pathology images to identify dying tumors that have responded to therapy, which would allow those patients to avoid unnecessary further surgeries and complications.

Other

Stanford Medicine develops Nuclei.io, which helps pathologists diagnose endometritis and metastatic colon cancer with higher speed and accuracy than pathologists alone. The AI system observes individual pathologist behavior – such as image clicking and enlarging —  to learn what they are looking for and which cells are important.

Contacts

Mr. H, Lorre, Jenn, Dr. Jayne.
Get HIStalk updates.
Send news or rumors.
Contact us.